Talus Bio

Talus Bioscience

This company develops an AI-enabled drug discovery platform and small-molecule therapeutics for pharmaceutical and biotechnology organisations to target transcription factors.

Kronos Bio

This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.

Serna Bio

This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.

Pepper Bio

This company develops transomics software to identify biological targets and drug candidates for pharmaceutical and biotechnology researchers.

Revona Bio

The company develops an RNA-targeted drug discovery platform to identify small-molecule compounds for pharmaceutical partners and biotechnology firms.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

TippingPoint

TippingPoint Biosciences develops a drug discovery platform targeting disease-specific chromatin states to create therapies for cancers and other genome packaging disorders.

Veritas In Silico

The company develops an AI-driven drug discovery platform for identifying mRNA-targeted medicines for pharmaceutical industry partners.